Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca collaborates with CSPC Pharma focused on AI-enabled research

AstraZeneca Tagrisso with chemotherapy approved in US for EGFR-mutated advanced lung cancer

Ruchika Sharma17 Feb 2024 12:00 PM IST

Tagrisso (osimertinib) is a third-generation, irreversible EGFR-TKI with proven clinical activity in NSCLC, including against CNS metastases.

Wockhardt loss narrows to Rs 86 crore in Q3

Ruchika Sharma17 Feb 2024 10:00 AM IST

New Delhi: Pharmaceuticals firm Wockhardt Ltd has reported narrowing of consolidated net loss to Rs 86 crore for the third quarter ended December...

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus Phase III CT Waiver Request for Voclosporin

Zydus Lifesciences secures USFDA okay for angina drug Isosorbide Mononitrate ER

Ruchika Sharma16 Feb 2024 3:52 PM IST

Ahmedabad: Pharma major Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food...

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

Lupin bags USFDA nod for pregnancy prevention drug Minzoya

Ruchika Sharma16 Feb 2024 3:02 PM IST

Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy.

Sun Pharma, Alembic and 1 other recall products

Philips recall of imaging machines classified as most serious by USFDA

Ruchika Sharma16 Feb 2024 1:30 PM IST

There has been one incident related to use of the device, but no reports of injuries or deaths, the FDA said.

Cipla inks pacts to invest in iCaltech Innovations

Cipla, CSIR-CDRI to jointly develop novel ophthalmic formulation for fungal keratitis

Ruchika Sharma16 Feb 2024 12:30 PM IST

Mumbai: Cipla Limited has announced that the company has entered into a collaborative research agreement with CSIR-Central Drug Research Institute...

Lupin receives USFDA observations for two Pithampur manufacturing Units

Lupin unveils Ganirelix Acetate Injection in US

Ruchika Sharma16 Feb 2024 11:24 AM IST

It is indicated for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation.

Mylan Labs license to manufacture Alprazolam cancelled by Telangana DCA

Ruchika Sharma15 Feb 2024 4:30 PM IST

DCA Telangana issued a show cause notice to Mylan Laboratories Unit-7 upon carrying out an inspection of the site, as the firm failed to notify the...

CureVac announces resolution of patent litigation with Pfizer/BioNTech

Pfizer agrees to pay USD 93 million to settle cholesterol drug Lipitor antitrust lawsuit

Ruchika Sharma15 Feb 2024 2:16 PM IST

Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy...

Natco Pharma reports over 3-fold rise in net profit at Rs 212.7 crore in Q3

Ruchika Sharma15 Feb 2024 12:30 PM IST

Hyderabad: Natco Pharma Ltd has reported over three-fold rise in consolidated net profit at Rs 212.7 crore in the third quarter ended December...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

Bristol Myers Squibb application for Augtyro for NTRK-Positive Locally Advanced or Metastatic Solid Tumors accepted by USFDA for priority review

Ruchika Sharma15 Feb 2024 11:13 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug...

Gland Pharma Pashamylaram facility receives GMP compliance certificate from Danish Medicines Agency

Gland Pharma posts Rs 192 crore profit after tax in Q3

Ruchika Sharma15 Feb 2024 10:00 AM IST

New Delhi: Gland Pharma has said its consolidated Profit After Tax (PAT) stood at Rs 192 crore for the December quarter.The drug firm had reported a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok